Literature DB >> 8554056

Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample.

G Jarvik1, E B Larson, K Goddard, G D Schellenberg, E M Wijsman.   

Abstract

The epsilon 4 allele of the apolipoprotein E locus (APOE) has been found to be an important predictor of Alzheimer disease (AD). However, linkage analysis has not clarified the role of APOE in the transmission of AD. The results of the current study provide evidence that the pattern of transmission of memory disorders differs in nuclear families in which the AD-affected proband did carry an epsilon 4 allele versus those families in which the AD-affected proband did not carry an epsilon allele. Further, risk of AD due to APOE genotype in the probands is modified by family history of memory disorders, suggesting gene-by-gene interactions. Family history remained a significant predictor of AD for affected probands with some, but not all, APOE genotypes in a logistic regression analysis. Though nonadditive in the prediction of AD, APOE genotype and family history acted additively in the prediction of age at AD onset. The results of complex segregation analysis were inconsistent with Mendelian segregation of memory disorders both in families of affected probands who did or did not carry an epsilon 4 allele, yet these two groups had significantly different parameter estimates for their transmission models. These results are consistent with gene-by-gene interactions, but also could result from common elements in the familial environment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8554056      PMCID: PMC1914964     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  34 in total

1.  University of Washington Alzheimer's Disease Patient Registry (ADPR): 1987-1988.

Authors:  E B Larson; W A Kukull; L Teri; W McCormick; M Pfanschmidt; G van Belle; M Sumi
Journal:  Aging (Milano)       Date:  1990-12

2.  Segregation analysis reveals evidence of a major gene for Alzheimer disease.

Authors:  L A Farrer; R H Myers; L Connor; L A Cupples; J H Growdon
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

3.  Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage.

Authors:  M A Pericak-Vance; J L Bebout; P C Gaskell; L H Yamaoka; W Y Hung; M J Alberts; A P Walker; R J Bartlett; C A Haynes; K A Welsh
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

4.  Risk factors in Alzheimer's disease: a clinicopathologic study.

Authors:  M F Mendez; K L Underwood; B A Zander; A R Mastri; J H Sung; W H Frey
Journal:  Neurology       Date:  1992-04       Impact factor: 9.910

5.  Increased platelet membrane fluidity as a diagnostic marker for Alzheimer's disease: a test in population-based cases and controls.

Authors:  W A Kukull; T R Hinds; G D Schellenberg; G van Belle; E B Larson
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

6.  Apolipoprotein E polymorphism and Alzheimer's disease.

Authors:  J Poirier; J Davignon; D Bouthillier; S Kogan; P Bertrand; S Gauthier
Journal:  Lancet       Date:  1993-09-18       Impact factor: 79.321

7.  The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease.

Authors:  C E Yu; H Payami; J M Olson; M Boehnke; E M Wijsman; H T Orr; W A Kukull; K A Goddard; E Nemens; J A White
Journal:  Am J Hum Genet       Date:  1994-04       Impact factor: 11.025

8.  Apolipoprotein E: risk factor for Alzheimer disease.

Authors:  M S Tsai; E G Tangalos; R C Petersen; G E Smith; D J Schaid; E Kokmen; R J Ivnik; S N Thibodeau
Journal:  Am J Hum Genet       Date:  1994-04       Impact factor: 11.025

9.  Genetic transmission of Alzheimer's disease among families in a Dutch population based study.

Authors:  C M van Duijn; L A Farrer; L A Cupples; A Hofman
Journal:  J Med Genet       Date:  1993-08       Impact factor: 6.318

10.  Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies.

Authors:  C M van Duijn; D Clayton; V Chandra; L Fratiglioni; A B Graves; A Heyman; A F Jorm; E Kokmen; K Kondo; J A Mortimer; W A Rocca; S L Shalat; H Soininen; A Hofman
Journal:  Int J Epidemiol       Date:  1991       Impact factor: 7.196

View more
  21 in total

Review 1.  The complexities of predictive genetic testing.

Authors:  J P Evans; C Skrzynia; W Burke
Journal:  BMJ       Date:  2001-04-28

Review 2.  Why should primary care physicians know about the genetics of dementia?

Authors:  L E Pinsky; W Burke; T D Bird
Journal:  West J Med       Date:  2001-12

Review 3.  Genetics for the general internist.

Authors:  Christina M Laukaitis
Journal:  Am J Med       Date:  2011-11-11       Impact factor: 4.965

4.  The demographic and medical correlates of plasma aβ40 and aβ42.

Authors:  Andrea L Metti; Jane A Cauley; Hilsa N Ayonayon; Tamara B Harris; Caterina Rosano; Jeff D Williamson; Kristine Yaffe
Journal:  Alzheimer Dis Assoc Disord       Date:  2013 Jul-Sep       Impact factor: 2.703

Review 5.  New approaches to genetic counseling and testing for Alzheimer's disease and frontotemporal degeneration.

Authors:  Jill S Goldman
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

Review 6.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

Review 7.  Alzheimer's disease: epidemiology, genetics, and beyond.

Authors:  Xiao-Ping Wang; Hong-Liu Ding
Journal:  Neurosci Bull       Date:  2008-04       Impact factor: 5.203

8.  Genetic basis of nondiabetic end-stage renal disease.

Authors:  Barry I Freedman; Rulan S Parekh; W H Linda Kao
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

9.  Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex.

Authors:  H Bickeböller; D Campion; A Brice; P Amouyel; D Hannequin; O Didierjean; C Penet; C Martin; J Pérez-Tur; A Michon; B Dubois; F Ledoze; C Thomas-Anterion; F Pasquier; M Puel; J F Demonet; O Moreaud; M C Babron; D Meulien; D Guez; M C Chartier-Harlin; T Frebourg; Y Agid; M Martinez; F Clerget-Darpoux
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

10.  A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype.

Authors:  H Payami; H Grimslid; B Oken; R Camicioli; G Sexton; A Dame; D Howieson; J Kaye
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.